New Comprehensive Stool Profile tests are not available at the test of choice for optimizing clinical value in managing gut health and has been enhanced to now offer:
- Further insight into gut flora by identifying 24 Commensal Bacteria targets using PCR technology
- Identification of parasites using O&P technology
- Biomarkers indicating levels of digestive and absorptive functions, as well as potential issues with gut inflammation and immunology
Why use targeted stool testing?
Gastrointestinal function is critical for good health. The intestinal tract contains significant amounts of bacteria which, when imbalanced, scientific literature has associated with a wide variety of common illnesses including, but not limited to:
- Irritable Bowel Syndrome (IBS)
- Inflammatory Bowel Disease (IBD)
- Autoimmune Disorders
- Cardiovascular Disease
Additionally, balancing gut microbiota is key for improving core gastrointestinal functions, such as digestion and absorption of nutrients, as well as metabolic functions. Poor digestion and malabsorption may impact immune function, optimum nutritional status, and mood.
Why is the GI Effects Comprehensive Stool Profile the best stool test for gastrointestinal diagnostics?
By evaluating targeted biomarkers, the GI Effects Comprehensive Stool Profile can reveal hidden conditions that other stool tests may overlook. Now with the use of Calprotectin, the GI Effects Comprehensive Stool Profile is a simple, yet more superior stool test that has the ability to differentiate Irritable Bowel Syndrome from Inflammatory Bowel Disease. Other benefits include:
- More Actionable Results
GI Effects Stool Profiles utilize the best technologies available to manage gut health, including enhanced molecular (PCR) technical performance, an expanded number of commensal targets, detection of parasites, and premier inflammatory and metabolic biomarkers – all designed to increase the prevalence of clinically actionable results.
- Enhanced Clinical Utility
Our value-added report provides Interpretation At-a-Glance that provides immediate treatment insight via key biomarkers for Infection, Inflammation, Insufficiency, and Imbalances by using graphics designed to place immediate focus on the big picture. The Interpretation At-a-Glance also summarizes commensal bacterial patterns into global markers of gut health in a Diversity Association graphic. As well, our Relative Abundance graphic provides a comparison of the patient’s microbial abundance to a healthy cohort of patients.
- Option of 1-Day or 3-Day Specimen Collection
Our GI Effects Stool Profiles allow the choice of either one- or three-day collection based on your clinical concerns and the needs of your patient.
Genova uses stool ova and parasites (O&P) testing to detect parasites and their eggs within the gastrointestinal tract. While literature suggests that >90% of enteric parasitic infections may be detected in a sample from a single (or one day) stool collection, increased sensitivity results from the collection of additional specimens on separate days – and collection of multiple samples is the clinical gold standard for assessing parasitic infection in patients for whom there is a high clinical index of suspicion.
- NEW Biomarkers & Add-ons
The GI Effects Comprehensive Stool Profile now includes biomarkers such as Calprotectin and Pancreatic Elastase 1, as well as premier inflammatory and metabolic biomarkers such as EPX and Beta-glucaronidase. It also offers five additional add-ons – including EIA assessment of pathogenicbacteria – for greater utility: HpSA – H.pylori, Campylobacterspp, Clostridium difficile, Shiga toxin E. coli and Fecal Lactoferrin.